Material properties and in vitro biocompatibility of a newly developed bone cement
AUTOR(ES)
Mitzner, Elke, Pelt, Paco Albertus Hubert Maria, Mueller, Christian, Strohwig, Angela, Mueller, Wolf-Dieter
FONTE
Materials Research
DATA DE PUBLICAÇÃO
2009
RESUMO
In this study mechanical properties and biocompatibility (In Vitro) of a new bone cement were investigated. A new platform technology named COOL is a variable composite of dissolved, chemically modified PMMA and different bioceramics. COOL cures at body temperature via a classical cementation reaction. Compressive strengths ranging from 3.6 ± 0.8 to 62.8 ± 1.3 MPa and bending strengths ranging from 9.9 ± 2.4 to 26.4 ± 3.0 MPa were achieved with different COOL formulations. Porosity varied between 31 and 43%. Varying the components of each formulation mechanical properties and porosity could be adjusted. In Vitro biocompatibility studies with primary human osteoblasts (pHOB) in direct contact with different COOL formulations, did not reveal any signs of toxicity. In contrast to Refobacin® R, cells incubated with COOL showed similar density, viability and ALP activity compared to control, if specimen were added immediately to the cell monolayer after preparation. In conclusion, COOL has promising mechanical properties in combination with high biocompatibility In Vitro and combines different advantages of both CPCs and PMMA cements by avoiding some of the respective shortcomings.
Documentos Relacionados
- In vitro and in vivo evaluation of lyophilized bovine bone biocompatibility
- In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
- Asthmagenic properties of a newly developed detergent ingredient: sodium iso-nonanoyl oxybenzene sulphonate.
- In Vitro Testing of Antimicrobial Activity of Bone Cement
- Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.